TOL has delivered a good FY set of numbers with profit up a solid 5.7%. This is a pretty solid result during difficult times, but I guess the market is greedy and TOL's SP has been trashed!
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status